Archive - The Microdose

Welcome to The Microdose

There has never been a more exciting – or bewildering – time in the world of psychedelics. Sign up. A newsletter from the U.C. Berkeley Center for the…

Oct 28, 2021 •

Mixing antidepressants and psychedelics: 5 Questions for psychopharmacologist Kelan Thomas

Thomas discusses what we know — and don’t know — about potential interactions between psychedelics and SSRIs.

Jun 5, 2023 •

A message to readers of The Microdose, from Michael Pollan & the BCSP

A note from the publisher of The Microdose

Dec 20, 2023 •

and

The Psychedelic Scrapbook

What do people see when they’re tripping?: 5 Questions for neuroscientist Sean Noah

Noah discusses what analyzing Erowid's trip reports can tell us about psychedelics and human vision.

Feb 24 •

“You can be humbled by a trip”: 5 Questions for Zen Buddhist priest Kokyo Henkel

Henkel explains what how he thinks Buddhist practice might benefit psychonauts and how psychedelic practice might benefit Buddhists.

Mar 10 •

The risks of mixing ayahuasca and SSRIs: 5 Questions for UCLA psychiatry professor Charles Grob

Grob discusses ayahuasca's risks, his research on the substance, and the growing need for new ayahuasca studies.

Jan 6 •

Sex & Psychedelics: 5 Questions for magazine founder Sura Hertzberg

Hertzberg discusses her vision for her magazine and how it came together.

Jan 27 •

Not everything’s bigger in Texas

I went to SXSW and learned about “the mullet” approach to psychedelics

Mar 12 •

New Mexico poised to become third state with a regulated psilocybin program; Low doses of LSD for ADHD no more effective than placebo; State…

Plus: Ukraine Ministry of Health proposes rescheduling psychedelics; and clinician survey highlights barriers to psychedelic-assisted therapies

Mar 21 •

RFK Jr.’s first acid trip, and federal health leaders appear to be keen on psychedelics; The rise of ketamine use disorder

Plus: The State of Psychedelics, and how moments of “insight” contribute to psychedelics’ therapeutic effects

May 2 •

The power of “know-cebo”: 5 Questions for data scientist Balázs Szigeti

Szigeti discusses expectancy effects, unblinding, and how researchers might design better studies on psychedelics.

Mar 24 •

Breaking News: F.D.A. Panel Votes Against MDMA-Assisted Therapy for PTSD

On Tuesday, the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee voted overwhelmingly to reject MDMA-assisted therapy in the…

Jun 5, 2024 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts